{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T00:16:27Z","timestamp":1761178587952,"version":"build-2065373602"},"reference-count":19,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer\/Radioth\u00e9rapie"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.canrad.2022.08.009","type":"journal-article","created":{"date-parts":[[2023,2,11]],"date-time":"2023-02-11T08:13:52Z","timestamp":1676103232000},"page":"183-188","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["A new prognostic model for brain metastases of specific primary tumors with stereotactic radiotherapy"],"prefix":"10.1016","volume":"27","author":[{"given":"L.","family":"Gu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Qing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.-J.","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.canrad.2022.08.009_bib0100","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1038\/bjc.2012.163","article-title":"Incidence and time trends of brain metastases admissions among breast cancer patients in Sweden","volume":"106","author":"Frisk","year":"2012","journal-title":"Br J Cancer"},{"key":"10.1016\/j.canrad.2022.08.009_bib0105","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1002\/cncr.30000","article-title":"Risk of brain metastases in patients with nonmetastatic lung cancer: Analysis of the Metropolitan Detroit Surveillance, Epidemiology, and End Results (SEER) data","volume":"122","author":"Goncalves","year":"2016","journal-title":"Cancer"},{"key":"10.1016\/j.canrad.2022.08.009_bib0110","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.1200\/JCO.2004.12.149","article-title":"Incidence proportions of brain metastases in patients diagnosed (1973 to 2001) in the Metropolitan Detroit Cancer Surveillance System","volume":"22","author":"Barnholtz-Sloan","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2022.08.009_bib0115","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1038\/nrclinonc.2011.58","article-title":"The biology of brain metastases-translation to new therapies","volume":"8","author":"Eichler","year":"2011","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.canrad.2022.08.009_bib0120","doi-asserted-by":"crossref","DOI":"10.4103\/2152-7806.111298","article-title":"Imaging of brain metastases","volume":"4","author":"Fink","year":"2013","journal-title":"Surg Neurol Int"},{"key":"10.1016\/j.canrad.2022.08.009_bib0125","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1016\/S0140-6736(04)16250-8","article-title":"Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial","volume":"363","author":"Andrews","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.canrad.2022.08.009_bib0130","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.ijrobp.2014.07.002","article-title":"Secondary analysis of RTOG 9508, a phase 3 randomized trial of whole-brain radiation therapy versus WBRT plus stereotactic radiosurgery in patients with 1-3 brain metastases; poststratified by the graded prognostic assessment (GPA)","volume":"90","author":"Sperduto","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2022.08.009_bib0135","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.ijrobp.2009.08.025","article-title":"Diagnosis-specific prognostic factors, indexes, and treatment outcomes for patients with newly diagnosed brain metastases: a multi-institutional analysis of 4,259 patients","volume":"77","author":"Sperduto","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2022.08.009_bib0140","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1186\/1748-717X-7-181","article-title":"EGFR mutations are associated with favorable intracranial response and progression-free survival following brain irradiation in non-small cell lung cancer patients with brain metastases","volume":"7","author":"Lee","year":"2012","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.canrad.2022.08.009_bib0145","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.lungcan.2013.06.004","article-title":"Impact of epidermal growth factor receptor mutations on intracranial treatment response and survival after brain metastases in lung adenocarcinoma patients","volume":"81","author":"Hsiao","year":"2013","journal-title":"Lung Cancer"},{"key":"10.1016\/j.canrad.2022.08.009_bib0150","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1111\/1759-7714.12460","article-title":"Prognostic model for brain metastases from lung adenocarcinoma identified with epidermal growth factor receptor mutation status","volume":"8","author":"Li","year":"2017","journal-title":"Thorac Cancer"},{"key":"10.1016\/j.canrad.2022.08.009_bib0155","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.radonc.2013.01.015","article-title":"The clinical utility of prognostic scoring systems in patients with brain metastases treated with radiosurgery","volume":"106","author":"Zindler","year":"2013","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2022.08.009_bib0160","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.radonc.2014.04.012","article-title":"A prospective study comparing the predictions of doctors versus models for treatment outcome of lung cancer patients: a step toward individualized care and shared decision making","volume":"112","author":"Oberije","year":"2014","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2022.08.009_bib0165","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1200\/JCO.2011.38.0527","article-title":"Summary report on the graded prognostic assessment: an accurate and facile diagnosis-specific tool to estimate survival for patients with brain metastases","volume":"30","author":"Sperduto","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2022.08.009_bib0170","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/S0360-3016(96)00619-0","article-title":"Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials","volume":"37","author":"Gaspar","year":"1997","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2022.08.009_bib0175","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1001\/jamaoncol.2016.3834","article-title":"Estimating survival in patients with lung cancer and brain metastases: an update of the graded prognostic assessment for lung cancer using molecular markers (Lung-molGPA)","volume":"3","author":"Sperduto","year":"2017","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.canrad.2022.08.009_bib0180","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1200\/JCO.2016.69.7144","article-title":"Management of brain metastases in tyrosine kinase inhibitor-naive epidermal growth factor receptor-mutant non-small-cell lung cancer: a retrospective multi-institutional analysis","volume":"35","author":"Magnuson","year":"2017","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2022.08.009_bib0185","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.cllc.2014.04.003","article-title":"An individual patient data metaanalysis of outcomes and prognostic factors after treatment of oligometastatic non-small-cell lung cancer","volume":"15","author":"Ashworth","year":"2014","journal-title":"Clin Lung Cancer"},{"key":"10.1016\/j.canrad.2022.08.009_bib0190","first-page":"4","article-title":"The revised TNM staging system for lung cancer","volume":"15","author":"Rami-Porta","year":"2009","journal-title":"Ann Thorac Cardiovasc Surg"}],"container-title":["Cancer\/Radioth\u00e9rapie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1278321823000070?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1278321823000070?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T12:36:29Z","timestamp":1761136589000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1278321823000070"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":19,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["S1278321823000070"],"URL":"https:\/\/doi.org\/10.1016\/j.canrad.2022.08.009","relation":{},"ISSN":["1278-3218"],"issn-type":[{"type":"print","value":"1278-3218"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A new prognostic model for brain metastases of specific primary tumors with stereotactic radiotherapy","name":"articletitle","label":"Article Title"},{"value":"Cancer\/Radioth\u00e9rapie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canrad.2022.08.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier Masson SAS on behalf of Soci\u00e9t\u00e9 fran\u00e7aise de radioth\u00e9rapie oncologique (SFRO).","name":"copyright","label":"Copyright"}]}}